Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma

Overview of attention for article published in Journal of Hepatocellular Carcinoma, January 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 289 followers.

Cisplatin/doxorubicin reduces cell viability in HCC | JHC - Dove Medical Press https://t.co/kh43jNJH1N